C₂₂H₂₂N₆O₇S₂ (P274)
Quantities
| P4250 | defined daily dose | 4 |
| P2067 | mass | 546.099139 |
| P3780 | active ingredient in | ... | Q47521331 (???) | ??? |
| P3780 | active ingredient in | ... | Q48828936 (???) | ??? |
| P233 | canonical SMILES | String | CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-] | ??? |
| P373 | Commons category | String | Ceftazidime | ??? |
| P703 | found in taxon | ... | Q772657 (Psathyrella candolleana) | Psathyrella candolleana |
| P703 | found in taxon | ... | Q10592612 (Myrothecium) | Myrothecium |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-] | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P2175 | medical condition treated | ... | Q221668 (urinary tract infection) | urinary tract infection |
| P2175 | medical condition treated | ... | Q34879 (staphylococcal infection) | staphylococcal infection |
| P2175 | medical condition treated | ... | Q183134 (sepsis) | sepsis |
| P2175 | medical condition treated | ... | Q242165 (hyperthermia) | hyperthermia |
| P2175 | medical condition treated | ... | Q727028 (bacterial infectious disease) | bacterial infectious disease |
| P2175 | medical condition treated | ... | Q1435822 (neutropenia) | neutropenia |
| P2175 | medical condition treated | ... | Q2622199 (upper respiratory tract infection) | upper respiratory tract infection |
| P2175 | medical condition treated | ... | Q3678510 (bacterial meningitis) | bacterial meningitis |
| P2175 | medical condition treated | ... | Q3776920 (bacterial pneumonia) | bacterial pneumonia |
| P2175 | medical condition treated | ... | Q4227886 (Escherichia coli infectious disease) | Escherichia coli infectious disease |
| P2175 | medical condition treated | ... | Q6029216 (infectious bone disease) | infectious bone disease |
| P2175 | medical condition treated | ... | Q7255052 (Pseudomonas infection) | Pseudomonas infection |
| P2175 | medical condition treated | ... | Q16935263 (Serratia infection) | Serratia infection |
| P2175 | medical condition treated | ... | Q19597369 (gram-negative bacterial infection) | gram-negative bacterial infection |
| P3489 | pregnancy category | ... | Q3679232 (Australian pregnancy category B1) | Australian pregnancy category B1 |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P3364 | stereoisomer of | ... | Q83126523 ((E)-ceftazidime) | (E)-ceftazidime |
| P9989 | stylized name | String | cefTAZidime | ??? |
| P279 | subclass of | ... | Q271021 (cephalosporin antibiotic) | cephalosporin antibiotic |
| P2868 | subject has role | ... | Q12187 (antibiotic) | antibiotic |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q427492 (enzyme inhibitor) | enzyme inhibitor |
| P2868 | subject has role | ... | Q804539 (bactericide) | bactericide |
| P12081 | WHO Aware Classification | ... | Q122925721 (watch) | watch |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | ceftazidime | ??? |
Why not click here or view trends?
log id: 303808